Regional Account Manager
Alexion
Regional Account Manager
Alexion
Global biopharmaceuticals focusing on rare diseases
Regional Account Manager, PNH, Milwaukee, WI
This is what you will do:
The Regional Account Manager (RAM) position is within our Hematology and Nephrology Franchise, a division of Alexion and will focus on PNH. The RAM will be assigned a sales territory focused on Academic Centers and Hospital Systems hospitals, private practices, and infusion centers, primarily focused on Hematology. This individual would be responsible for the growth and expansion of PNH portfolio and other products, following FDA approval, for appropriate specialists.
You will be responsible for:
You will need to have:
We would prefer for you to have:
The annual base salary for this position ranges from $152,813 to $229,219. However, base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program (salaried roles) or to receive a retirement contribution (hourly roles). Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans. Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.
Date Posted
02-Nov-2026Closing Date
24-Dec-2026Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.
Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.
Explore more opportunities at Alexion